May 1, 2024 – Patient Worthy

source: shutterstock.com

Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia

Post author:Rose Duesterwald
Post published:May 1, 2024
Post category:Beta Thalassemia Beta thalassemia major Beta Thalassemia Major

Exa-cel Gene-Edited Therapy Vertex Pharmaceutical recently announced that Health Canada has accepted its New Drug Submission and granted Priority Review for Exa-cel, a gene-edited cell therapy, for the treatment of…

Photo by Joshua J. Cotten on Unsplash

TMDU Researchers Develop Mouse Model for Anti-MDA5 Antibody-Positive Dermatomyositis

Post author:Jessica Lynn
Post published:May 1, 2024
Post category:Dermatomyositis

Developing an animal model of a disease can play an important role in both helping researchers to better understand that disease, as well as identifying and testing potential therapeutics. Animal…

source: pixabay.com

Is INOCA the Cause of Long COVID Chest Pain?

Post author:James Moore
Post published:May 1, 2024
Post category:COVID-19

According to a story published on tctmd.com, patients living with long COVID can experience a wide range of symptoms. One of these symptoms includes chest pain. Scientists weren't certain what…

Get Involved

Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia

TMDU Researchers Develop Mouse Model for Anti-MDA5 Antibody-Positive Dermatomyositis

Is INOCA the Cause of Long COVID Chest Pain?

Metastatic Breast Cancer: Navigating Grief

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

Get Involved

Let’s Work Together!

Keep Up to Date

Learn More